+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Leptospirosis Market by Technique (Culture, Molecular, Rapid), Product (Instruments, Kits, Reagents), End User, Application, Distribution Channel, Sample Type - Global Forecast 2025-2030- Product Image
Leptospirosis Market by Technique (Culture, Molecular, Rapid), Product (Instruments, Kits, Reagents), End User, Application, Distribution Channel, Sample Type - Global Forecast 2025-2030- Product Image
Sale

Leptospirosis Market by Technique (Culture, Molecular, Rapid), Product (Instruments, Kits, Reagents), End User, Application, Distribution Channel, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666170
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The leptospirosis market is navigating a period of significant transformation, as advanced diagnostics and evolving supply chain dynamics require senior leaders to adapt faster than ever. Stakeholders must rapidly assess shifting technologies, regulatory contexts, and regional needs to ensure stronger market positioning and resilient growth strategies.

Market Snapshot: Leptospirosis Diagnostics and Research Market Overview

The Leptospirosis Market grew from USD 585.30 million in 2024 to USD 648.16 million in 2025 and is projected to reach USD 1.06 billion by 2030, reflecting a CAGR of 10.44%. This robust performance signals ongoing investment, rising awareness, and growing demand for advanced detection methods that respond to both endemic and outbreak-driven needs across global healthcare, veterinary, and public health settings.

Scope & Segmentation: Comprehensive Analysis Across All Key Dimensions

This research report offers a granular evaluation of the leptospirosis market with a targeted lens on technologies, products, end users, applications, channels, sample types, and regions. Explore every segment with clear, actionable detail:

  • Diagnostic Techniques: Includes culture, molecular (PCR and real-time PCR), rapid tests (dot blot, lateral flow assay), and serological methods (IgM ELISA, latex agglutination, MAT).
  • Product Types: Covers instruments (ELISA readers, PCR thermocyclers), kits (ELISA, PCR, rapid test), and reagents (conjugate, substrate).
  • End Users: Spans diagnostic laboratories, hospitals and clinics, research institutes, and veterinary clinics.
  • Applications: Focuses on outbreak detection, routine diagnostics, and surveillance.
  • Distribution Channels: Encompasses direct sales, distributors, and online platforms.
  • Sample Types: Analyzes blood serum, cerebrospinal fluid, and urine, addressing pre-analytical challenges.
  • Regional Coverage: Segments into Americas (including US regions, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and more), and Asia-Pacific (China, India, Japan, Australia, among others).
  • Leading Companies: Evaluates Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim, Ceva Santé Animale, Elanco Animal Health, Thermo Fisher Scientific, Bio-Rad Laboratories, bioMérieux SA, Abbott Laboratories, and QIAGEN N.V.

Key Takeaways: Strategic Insights for Decision-Makers

  • The market’s evolution is closely linked to technological breakthroughs, including real-time PCR and rapid test formats, which are broadening the solutions available to clinicians.
  • Digital integration, such as smartphone readers and cloud platforms, is dramatically improving access to real-time epidemiological data and enhancing model-driven public health responses.
  • Stakeholder priorities are shifting towards modular, scalable diagnostic platforms that balance performance with cost efficiency — an imperative for highly varied regional healthcare systems.
  • Regionalization strategies in supply chain and reagent manufacturing are reducing trade-risk exposure and bolstering operational continuity in sensitive periods.
  • Leading companies are actively engaging in strategic partnerships, multipathogen assay development, and end-to-end solution integration to meet changing diagnostic and regulatory requirements.
  • Variability in regulatory harmonization, particularly across EMEA, is encouraging companies to tailor product configurations to fit both mature and emerging market infrastructures.

Tariff Impact on Supply Chain and Workflow Optimization

The 2025 United States tariff implementation has elevated acquisition and production costs throughout the supply chain, requiring distributors and laboratories to revise sourcing strategies. The effect includes diversification of supplier bases, increased domestic manufacturing, and renewed focus on cost-efficient assay design. These changes demand careful alignment of procurement practices, partnership models, and lean operational protocols to maintain steady access to essential reagents and equipment.

Methodology & Data Sources

This report employs a multi-source, evidence-based approach, combining primary interviews with industry leaders in microbiology, veterinary medicine, agriculture, and laboratory management. These findings are triangulated against peer-reviewed journals, regulatory documents, and public health records. Analytical rigor is ensured through expert validation, scenario analysis, and weighted data crosschecks to provide accurate, actionable intelligence.

Why This Report Matters: Value for Senior Leaders

  • Empower informed decisions with a holistic understanding of market segmentation, innovation trends, and regulatory drivers across diverse global regions.
  • Strengthen procurement and supply chain resilience with foresight into tariff impacts, sourcing strategies, and technology adoption best practices.
  • Identify optimal investment opportunities and partnership prospects by benchmarking leading players and reviewing their integrated commercial and research initiatives.

Conclusion

The leptospirosis market is poised for sustained innovation, shaped by advanced diagnostic technologies, responsive supply chains, and region-specific strategies. Senior decision-makers can leverage this comprehensive analysis to address evolving public health challenges and advance their market presence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of rapid point-of-care diagnostic assays for early leptospirosis detection in rural clinics
5.2. Growth of affordable multiplex testing platforms integrating leptospira biomarkers in emerging markets
5.3. Increasing funding for human and veterinary vaccine development targeting diverse leptospira serovars
5.4. Rising adoption of digital epidemiology tools for real-time leptospirosis outbreak surveillance in tropical regions
5.5. Collaborations between biotech firms and academic institutions to optimize leptospirosis immunodiagnostic kits
5.6. Government initiatives promoting One Health approaches to control leptospirosis transmission in urban environments
5.7. Impact of climate change on leptospirosis incidence driving investment in predictive modeling and control strategies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Leptospirosis Market, by Technique
8.1. Introduction
8.2. Culture
8.3. Molecular
8.3.1. PCR
8.3.2. Real Time PCR
8.4. Rapid
8.4.1. Dot Blot
8.4.2. Lateral Flow Assay
8.5. Serological
8.5.1. IgM Elisa
8.5.2. Latex Agglutination
8.5.3. Mat
9. Leptospirosis Market, by Product
9.1. Introduction
9.2. Instruments
9.2.1. ELISA Readers
9.2.2. PCR Instruments
9.3. Kits
9.3.1. ELISA Kits
9.3.2. PCR Kits
9.3.3. Rapid Test Kits
9.4. Reagents
9.4.1. Conjugate Reagents
9.4.2. Substrate Reagents
10. Leptospirosis Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals And Clinics
10.4. Research Institutes
10.5. Veterinary Clinics
11. Leptospirosis Market, by Application
11.1. Introduction
11.2. Outbreak Detection
11.3. Routine Diagnostics
11.4. Surveillance
12. Leptospirosis Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online
13. Leptospirosis Market, by Sample Type
13.1. Introduction
13.2. Blood Serum
13.3. Cerebrospinal Fluid
13.4. Urine
14. Americas Leptospirosis Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Leptospirosis Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Leptospirosis Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Zoetis Inc.
17.3.2. Merck & Co., Inc.
17.3.3. Boehringer Ingelheim International GmbH
17.3.4. Ceva Santé Animale
17.3.5. Elanco Animal Health Incorporated
17.3.6. Thermo Fisher Scientific Inc.
17.3.7. Bio-Rad Laboratories, Inc.
17.3.8. bioMérieux SA
17.3.9. Abbott Laboratories
17.3.10. QIAGEN N.V.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. LEPTOSPIROSIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LEPTOSPIROSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. LEPTOSPIROSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. LEPTOSPIROSIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. LEPTOSPIROSIS MARKET: RESEARCHAI
FIGURE 28. LEPTOSPIROSIS MARKET: RESEARCHSTATISTICS
FIGURE 29. LEPTOSPIROSIS MARKET: RESEARCHCONTACTS
FIGURE 30. LEPTOSPIROSIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LEPTOSPIROSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LEPTOSPIROSIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LEPTOSPIROSIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY RAPID, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY RAPID, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DOT BLOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DOT BLOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY IGM ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY IGM ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY LATEX AGGLUTINATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY LATEX AGGLUTINATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY MAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY MAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY ELISA READERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY ELISA READERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY ELISA KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY PCR KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY PCR KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY CONJUGATE REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY CONJUGATE REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SUBSTRATE REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SUBSTRATE REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY OUTBREAK DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY OUTBREAK DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY ROUTINE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY ROUTINE DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY BLOOD SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY BLOOD SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES LEPTOSPIROSIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 153. CANADA LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 154. CANADA LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 155. CANADA LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 156. CANADA LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 157. CANADA LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 158. CANADA LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 159. CANADA LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 160. CANADA LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 161. CANADA LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 162. CANADA LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 163. CANADA LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 164. CANADA LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 165. CANADA LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 166. CANADA LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 167. CANADA LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 168. CANADA LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 169. CANADA LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. CANADA LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. CANADA LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. CANADA LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. CANADA LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. CANADA LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. CANADA LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 176. CANADA LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 180. MEXICO LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 181. MEXICO LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 182. MEXICO LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 183. MEXICO LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 184. MEXICO LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 185. MEXICO LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 186. MEXICO LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 187. MEXICO LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. MEXICO LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. MEXICO LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. MEXICO LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. MEXICO LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. MEXICO LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 299. GERMANY LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 300. GERMANY LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 301. GERMANY LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 302. GERMANY LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 303. GERMANY LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 304. GERMANY LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 305. GERMANY LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 306. GERMANY LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 307. GERMANY LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 308. GERMANY LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 309. GERMANY LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 310. GERMANY LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 311. GERMANY LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 312. GERMANY LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 313. GERMANY LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 314. GERMANY LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 315. GERMANY LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. GERMANY LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. GERMANY LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. GERMANY LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. GERMANY LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. GERMANY LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. GERMANY LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 322. GERMANY LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 323. FRANCE LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 324. FRANCE LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 325. FRANCE LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 326. FRANCE LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 327. FRANCE LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 328. FRANCE LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 329. FRANCE LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 330. FRANCE LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 331. FRANCE LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 332. FRANCE LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 333. FRANCE LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 334. FRANCE LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 335. FRANCE LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 336. FRANCE LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 337. FRANCE LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 338. FRANCE LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 339. FRANCE LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 340. FRANCE LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 341. FRANCE LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 342. FRANCE LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 343. FRANCE LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. FRANCE LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. FRANCE LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 346. FRANCE LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 347. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 348. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 349. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 350. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 351. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2018-2024 (USD MILLION)
TABLE 352. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY RAPID, 2025-2030 (USD MILLION)
TABLE 353. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 354. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 355. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 356. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 357. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 358. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 359. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 360. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 361. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 362. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 363. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 364. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 365. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 366. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 367. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 368. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 369. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 370. RUSSIA LEPTOSPIROSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 371. ITALY LEPTOSPIROSIS MARKET SIZE, BY TECHNIQUE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Leptospirosis market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Elanco Animal Health Incorporated
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Abbott Laboratories
  • QIAGEN N.V.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 648.16 Million
Forecasted Market Value ( USD ) by 2030 $ 1060 Million
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Leptospirosis - Global Strategic Business Report - Product Image

Leptospirosis - Global Strategic Business Report

  • Report
  • 382 Pages
  • Global
From
Global Malaria Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Malaria Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 115 Pages
  • Global
From
Influenza Diagnostics Market by Technology (Molecular Diagnostics, Rapid Diagnostics, Serological Diagnostics), End User (Academic & Research Institutes, Clinics, Diagnostic Laboratories) - Global Forecast 2025-2030 - Product Image

Influenza Diagnostics Market by Technology (Molecular Diagnostics, Rapid Diagnostics, Serological Diagnostics), End User (Academic & Research Institutes, Clinics, Diagnostic Laboratories) - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Sexually Transmitted Diseases Diagnostics Market by Technology, Disease, End User, Distribution Channel, Test Type, Sample Type - Global Forecast to 2030 - Product Image

Sexually Transmitted Diseases Diagnostics Market by Technology, Disease, End User, Distribution Channel, Test Type, Sample Type - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Technology (Mass Spectrometry, PCR, in Situ Hybridization), Application, End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Technology (Mass Spectrometry, PCR, in Situ Hybridization), Application, End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.